Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 12:27 AM
Study NCT ID:
NCT04396860
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2020-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-20
First Submit QC Date:
None
Study First Post Date:
2020-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-09
Results First Submit QC Date:
None
Results First Post Date:
2024-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED